Quantum dots-amplified electrochemical cytochrome P450 phenotype sensor for tamoxifen, a breast cancer drug
Loading...
Date
2017
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
University of the Western Cape
Abstract
Breast cancer is regarded as the most common cancer in South Africa and its rate of
occurrence is increasing. About one in every 31 South African women are at the risk of
developing breast cancer and early diagnosis and treatment guarantee 90% survival rate.
Tamoxifen is the drugs of choice for the treatment of all stages of breast cancer. The drug
binds with estrogen receptor (ER) to minimize the transcription of estrogen dependent genes.
However, nearly 50% of ER-positive breast cancer patients either become resistant or fail to
respond to tamoxifen resulting in a serious clinical challenge in breast cancer management.
The Grand Health Challenges of South Africa includes the development of cost effective
diagnostic systems suitable for early detection of diseases and drug resistivity for timely
invention and better patient management.
Description
Philosophiae Doctor - PhD
Keywords
Breast cancer, Capping agents, Cyclic voltammetry (CV), Cytochrome P450 enzymes, Differential pulse voltammetry (DPV), Electrochemical phenotype sensors, Indinavir, Limit of detection (LOD), Palladium telluride, Quantum dots, Square wave voltammetry (SWV), Tamoxifen
Citation
Feleni, U. (2017). Quantum dots-amplified electrochemical cytochrome P450 phenotype sensor for tamoxifen, a breast cancer drug. PhD. University of the Western Cape